rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Surgery Partners, Inc.

SGRY · Nasdaq

Health CareProviders & FacilitiesAbove a falling average

SGRY stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 2.9% above that average now. Providers & Facilities: 43% of its 53 stocks in an uptrend (−4 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 52
Industry in uptrend
43% -4 in 4 wk
Insider buys, 12 months
$609K
Insider sales, 12 months
$2.6M
Officials’ trades on record
0
Institutions holding
176 (+8)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
27%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$2.9M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months12
Buyers · sellers1 · 6
WhoDidSharesTraded
Teresa DelucaDirectorbought10,000at $14.3518 Aug 2026filed 19 Aug 2026
Teresa DelucaDirectorbought11,250at $14.3318 Aug 2026filed 20 Aug 2026
Jason Eric EvansChief Executive Officersold20,400at $12.4716 Mar 2026filed 16 Mar 2026
David T. DohertyChief Financial Officersold8,867at $12.5016 Mar 2026filed 16 Mar 2026
Marissa BrittenhamChief Strategy Officersold3,657at $12.5413 Mar 2026filed 16 Mar 2026
Danielle BurkhalterChief Human Resources Officersold3,469at $12.8313 Mar 2026filed 16 Mar 2026
Jennifer BaldockChief Admin & Dev Officersold5,798at $13.1712 Mar 2026filed 16 Mar 2026
Marissa BrittenhamChief Strategy Officersold8,785at $13.706 Mar 2026filed 9 Mar 2026
William Trenton WebbAmerican Group Presidentsold272at $13.936 Mar 2026filed 9 Mar 2026
Danielle BurkhalterChief Human Resources Officersold7,736at $13.606 Mar 2026filed 9 Mar 2026
Jennifer BaldockChief Admin & Dev Officersold10,082at $13.706 Mar 2026filed 9 Mar 2026
David T. DohertyChief Financial Officersold14,574at $13.846 Mar 2026filed 9 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders176+8 on the quarter
New · exited38 · 30
Reported value$2.6B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Bain Capital Investors LLCunchanged · filed 14 Aug 202649,946,972$839.1M00.0%
Jupiter Topco LLCnew · filed 14 Aug 202613,882,155$233.2M+13,882,155
Pentwater Capital Management LPreduced · filed 14 Aug 202611,630,000$195.4M-1,025,000−8.1%
UBS Group AGreduced · filed 13 Aug 20268,573,413$144.0M-1,618,368−15.9%
BlackRock, Inc.added · filed 7 Aug 20266,241,503$104.9M+580,715+10.3%
KING STREET CAPITAL MANAGEMENT, L.P.reduced · filed 14 Aug 20266,058,141$101.8M-4,171,589−40.8%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 20264,943,713$83.1M-352,698−6.7%
Clearbridge Investments, LLCreduced · filed 13 Aug 20263,823,179$64.2M-294,877−7.2%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20263,737,712$62.8M+109,281+3.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20263,509,535$59.0M+78,740+2.3%
31 Mar 2023 – 30 Jun 2026
127156184Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Teresa DeLuca Company insiderDirector · last 18 Aug 20265 · 8
Blair E. Hendrix Company insiderDirector · last 18 Jun 20260 · 1
Brent Turner Company insiderDirector · last 5 Jun 20261 · 0
Clifford G. Adlerz Company insiderDirector · last 5 Jun 20260 · 0
John A. Deane Company insiderDirector · last 5 Jun 20260 · 1
Laura L. Forese Company insiderDirector · last 5 Jun 20260 · 0
Lloyd H. Dean Company insiderDirector · last 5 Jun 20260 · 0
David T. Doherty Company insiderChief Financial Officer · last 16 Mar 20260 · 23
Jason Eric Evans Company insiderChief Executive Officer · last 16 Mar 20261 · 20
Danielle Burkhalter Company insiderChief Human Resources Officer · last 13 Mar 20260 · 16
Marissa Brittenham Company insiderChief Strategy Officer · last 13 Mar 20260 · 7
Jennifer Baldock Company insiderChief Admin & Dev Officer · last 12 Mar 20260 · 21

Same industry

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202511.8%
Free cash flow marginFY 2025 · to 31 Dec 20255.9%
Return on capital employedFY 2025 · to 31 Dec 20255.2%
Debt to equityFY 2025 · to 31 Dec 20252.18×
Share count trendFY 2025 · to 23 Feb 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$239.9M
Free cash flowFY 2025 · to 31 Dec 2025$195.6M

Analyst forecasts

No analyst forecasts yet.